BOOK ONLINE

Please select the service you would like to book:

search-button

MSI Reproductive Choices UK comment on the reclassification of the progestogen-only pill

Press releases  •  9 July 2021  • 2 min read

Share






Copied


Media statement

London, 9th July 2021

If you are covering the reclassification of the progestogen-only pill, you may find the following statement from MSI Reproductive Choices UK helpful.

Simphiwe Sesane contraceptive nurse and faculty registered trainer at MSI Reproductive Choices said:

“The reclassification of the progestogen-only pill, which can now be sold directly by a pharmacist without a prescription, is a great step forward. It will improve access and provide anyone seeking an extremely safe method of contraception more choice over how and where they access it. All too often our teams speak to people who have become pregnant while on contraception waiting lists and these challenges have only been exacerbated by the global pandemic, so this initiative is especially welcome in that context.

“However, while this reclassification is a positive move, cost will be a barrier for some. Progestogen-only contraception will continue to be available at no cost from GPs and sexual and reproductive health services, but ultimately we would like to see it available for free through NHS community pharmacies too.”

For further information please contact:

Email: [email protected]

Telephone: +44 (0) 7769 166 516


Share






Copied

Related posts

News


11 June 2020  • 2 min read

2019 Abortion Statistics for England and Wales

Media statement London, 11th June 2020 – If you are covering today’s 2019 Abortion Statistics for

News


24 February 2022  • 3 min read

MSI Reproductive Choices comment on six-month extension for at-home early medical abortion

MSI Reproductive Choices comment on six-month extension for at-home early medical abortion Media statement London,

News


5 June 2020  • 1 min read

Northern Ireland abortion regulations

Marie Stopes UK joins a group of professional medical bodies, service providers, and human rights organisation